Picture Name

OoCs

Build the whole industry chain ecosystem of organ chip technology, insight into the mystery of life science, help medical science and technology reform, and meet the individual needs of patients.

Full line of products

Recent news

Picture Name

Hot Enrollment | Advanced Training Camp for Organoids and Organ-on-a-Chip

Organoids and organ-on-a-chip in vitro models can well simulate the structure and function of the source tissue, and currently have great application potential in basic research and drug development. To promote the wide application of this cutting-edge technology, the "Organoids and Organ-on-a-Chip Advanced Training Camp" will be held on May 26-27.

Learn more>

Picture Name

Breaking the 'animal method bias': Methodological innovation is urgently needed for scientific and technological innovation

In recent years, "animal-methods bias" has become a hotly debated topic in the scientific community. This phenomenon refers to the forced use of animal models by researchers even when unnecessary, in order to meet the implicit requirements of journals and funding agencies. This bias not only may hinder scientific progress but also has a profound impact on the career choices of early-career researchers. Catharine Krebs and her team conducted a landmark survey involving 90 life scientists and peer reviewers worldwide, collecting their attitudes and opinions on animal models and alternatives, as well as the challenges and opportunities facing animal alternatives.

Learn more>

Picture Name

Break the mold! Organ-on-a-chip models open up new avenues for infectious disease research

The interplay between pathogens, host tissues, the immune system, and the microbiome plays a significant role in the study of microbial infection processes. Global healthcare systems are facing an increasing number of opportunistic infections, linked to the rise of antimicrobial resistance and the emergence of novel pathogens. Therefore, a deep understanding of microbial infections is crucial for advancing the development of new diagnostic tools and therapeutic strategies.

Learn more>

Picture Name

Witness to history! FDA announces new regulations to fully promote organ chip substitution for animal model testing

On April 11, 2025, the drug regulatory system underwent significant changes. The US Food and Drug Administration (FDA) issued a historic statement today, planning to gradually phase out traditional animal experiments and instead use laboratory grown organoids and organ-on-a-chip systems to test drug safety. Pharmaceutical companies will be allowed to submit non animal experimental data based on organoids and organ-on-a-chip as approval criteria, with priority given to companies adopting innovative testing strategies.

Learn more>

We use optional cookies to improve your experience on our website, including through social media connections, and to personalize ads based on your online activity. If you refuse optional cookies, we will only use cookies that are necessary to provide you with the services.Privacy Statement